These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17942910)

  • 21. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.
    Kaenel P; Schwab C; Mülchi K; Wotzkow C; Andres AC
    Int J Oncol; 2011 Jan; 38(1):151-60. PubMed ID: 21109936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of tumor growth and angiogenesis by soluble EphB4.
    Martiny-Baron G; Korff T; Schaffner F; Esser N; Eggstein S; Marmé D; Augustin HG
    Neoplasia; 2004; 6(3):248-57. PubMed ID: 15153337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.
    Davies MH; Zamora DO; Smith JR; Powers MR
    Microvasc Res; 2009 May; 77(3):382-6. PubMed ID: 19232363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
    Xue C; Huang Z; Wang J; Dong Y; Zhou X
    Can J Ophthalmol; 2009 Apr; 44(2):185-8. PubMed ID: 19491953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.
    Shin D; Garcia-Cardena G; Hayashi S; Gerety S; Asahara T; Stavrakis G; Isner J; Folkman J; Gimbrone MA; Anderson DJ
    Dev Biol; 2001 Feb; 230(2):139-50. PubMed ID: 11161568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.
    Wang L; Zhang J; Wang C; Qi Y; Du M; Liu W; Yang C; Yang P
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27726217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
    Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
    Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1.
    Zhang JS; Wang YZ; Hu YQ; Lin F; Gao D; Song J; Kaptchuk TJ; Chen KJ
    Chin J Integr Med; 2016 Aug; 22(8):605-10. PubMed ID: 27299459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis.
    Yuan K; Hong TM; Chen JJ; Tsai WH; Lin MT
    Blood; 2004 Aug; 104(4):1025-33. PubMed ID: 15126321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EphB4 forward signalling regulates lymphatic valve development.
    Zhang G; Brady J; Liang WC; Wu Y; Henkemeyer M; Yan M
    Nat Commun; 2015 Apr; 6():6625. PubMed ID: 25865237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells.
    Chen K; Bai H; Liu Y; Hoyle DL; Shen WF; Wu LQ; Wang ZZ
    J Cell Biochem; 2015 Mar; 116(3):467-75. PubMed ID: 25359705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.
    Kumar SR; Singh J; Xia G; Krasnoperov V; Hassanieh L; Ley EJ; Scehnet J; Kumar NG; Hawes D; Press MF; Weaver FA; Gill PS
    Am J Pathol; 2006 Jul; 169(1):279-93. PubMed ID: 16816380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
    Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
    Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.
    Yang C; Guo Y; Jadlowiec CC; Li X; Lv W; Model LS; Collins MJ; Kondo Y; Muto A; Shu C; Dardik A
    J Surg Res; 2013 Jul; 183(1):478-86. PubMed ID: 23394931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of angiogenic signaling pathways in hemangioblastoma.
    Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
    Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
    Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
    Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.
    Pennisi A; Ling W; Li X; Khan S; Shaughnessy JD; Barlogie B; Yaccoby S
    Blood; 2009 Aug; 114(9):1803-12. PubMed ID: 19597185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.
    Kimura M; Kato Y; Sano D; Fujita K; Sakakibara A; Kondo N; Mikami Y; Tsukuda M
    Int J Oncol; 2009 Feb; 34(2):321-7. PubMed ID: 19148465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
    Bhatia S; Bukkapatnam S; Van Court B; Phan A; Oweida A; Gadwa J; Mueller AC; Piper M; Darragh L; Nguyen D; Gilani A; Knitz M; Bickett T; Green A; Venkataraman S; Vibhakar R; Cittelly D; Karam SD
    Mol Carcinog; 2020 Sep; 59(9):1064-1075. PubMed ID: 32567728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.
    Lennon S; Oweida A; Milner D; Phan AV; Bhatia S; Van Court B; Darragh L; Mueller AC; Raben D; Martínez-Torrecuadrada JL; Pitts TM; Somerset H; Jordan KR; Hansen KC; Williams J; Messersmith WA; Schulick RD; Owens P; Goodman KA; Karam SD
    Clin Cancer Res; 2019 Jun; 25(11):3352-3365. PubMed ID: 30944125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.